The Supreme Court issued an order on Wednesday denying a request from the Trump administration to implement a Bureau of Prisons (BOP) policy regarding transgender inmates. The policy in question sought to taper hormone treatments for inmates currently receiving them and would have prohibited the initiation of new gender-affirming surgeries.

By refusing to lift the injunction imposed by a lower court, the Supreme Court ensures that current medical protocols for transgender inmates remain unchanged for the time being. The order was issued without a full opinion, though Justices Clarence Thomas and Samuel Alito publicly noted their dissent, indicating they would have granted the administration's request to stay the lower court's ruling.

The legal dispute centers on the extent of the Bureau of Prisons' authority to manage medical care for incarcerated individuals and whether the proposed policy changes would violate the constitutional rights of transgender inmates. While the majority of the court declined to intervene, the disagreement between the justices highlights the ongoing judicial debate over the intersection of administrative policy and the medical needs of prisoners. The administration had argued that the policy was necessary for operational consistency, while opponents maintained that the restrictions would cause irreparable harm to the health and well-being of the affected inmates.